Eric Shen

DR. ERIC SHEN joined RCM Capital Management in 2001 as an Analyst in the
healthcare group, covering biotechnology. Prior to joining RCM, Dr. Shen
was a Biotechnology Analyst at Robertson Stephens, where he covered
product-focused biotechnology companies. Dr. Shen graduated from Yale
University magna cum laude with a BA in Biology and received an MD from
New York University. He trained in internal medicine and radiology at
Massachusetts General Hospital and Stanford University Hospital